A novel platform to produce human monoclonal antibodies The next generation of therapeutic human monoclonal antibodies discovery

作者：Duvall Marcus; Bradley Norma; Fiorini Ryan N^*

来源：mAbs, 2011, 3(2): 203-208.

DOI：10.4161/mabs.3.2.14774

• human
• antibody
• monoclonal
• novel platform
• naive
• B cell
• therapeutic

A new technology has been developed by immunologix that allows human antibodies to be quickly generated against virtually any antigen. Using a novel process, naive human B cells are isolated from tonsil tissue and transformed with efficiency up to 85%, thus utilizing a large portion of the human VDJ/VJ repertoire. Through ex vivo stimulation, the B cells class switch and may undergo somatic hypermutation, thus producing a human "library" of different IgG antibodies that can then be screened against any antigen. Since diversity is generated ex vivo, sampling immunized or previously exposed individuals is not necessary. Cells producing the antibody of interest can be isolated through limiting dilution cloning and the human antibody from the cells can be tested for biological activity. No humanization is necessary because the antibodies are produced from human B cells. By eliminating immunization and humanization steps and screening a broadly diverse library, this platform should reduce both the cost and time involved in producing therapeutic monoclonal antibody candidates.

• 出版日期2011-4